Avalo Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 3 published signal records.
Avalo Therapeutics last closed at $13.65 (+1.64%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -5.8×. Its overall grade ranks 355 of 738 stocks in Healthcare.
About this company
Avalo Therapeutics last closed at $13.65 (+1.64%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 355/738
Valuation grade B
Related stocks
- AstraZenecaCompetitor
희귀질환·면역질환 치료제 개발 영역에서 경쟁
- SanofiCompetitor
면역·염증성 질환 치료제 시장에서 경쟁
- Regeneron PharmaceuticalsCompetitor
면역질환 및 항체 기반 바이오의약품 경쟁사
About Avalo Therapeutics
- What technical signals does Avalo Therapeutics (AVTX) have?
- Avalo Therapeutics current technical signals: no active technical signal.
- Is Avalo Therapeutics a cup-and-handle pattern?
- No. Avalo Therapeutics has no valid Cup signal right now.
- What published figures are available for Avalo Therapeutics?
- Market cap: $247.53M. Trailing 12 months PER: -5.8×. Latest quarter PBR: 1.31×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Avalo Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.